Kodiak Sciences (KOD) Climbs Nearly 3x on Promising Wet AMD Trial
Kodiak Sciences Inc.
Kodiak Sciences Inc. (KOD)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | SilverArc Capital Devesh Gandhi | 750,170 | $71,116,116 | +38% | 8.32% |
| 2. | Renaissance Technologies Jim Simons | 90,900 | $8,617,320 | -52% | 0.01% |
| 3. | Bayforest Capital Theodoros Tsagaris | 2,727 | $258,520 | +1% | 0.38% |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $98.51 | 81,729 | $8,051,123.79 | 20,424,859 | 2026-11-05 | Filing | |
| $98.51 | 4,703 | $463,292.53 | 1,683,172 | 2026-11-05 | Filing | |
| $98.51 | 151,916 | $14,965,245.16 | 20,343,130 | 2026-11-04 | Filing | |
| $98.51 | 8,742 | $861,174.42 | 1,678,469 | 2026-11-04 | Filing | |
| $85.89 | 1,416 | $121,613.87 | 20,191,214 | 2026-09-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $94.91 | 100 | $9,491.00 | 211,930 | 2026-10-21 | Filing | |
| $93.71 | 2,000 | $187,420.00 | 212,030 | 2026-10-21 | Filing | |
| $92.66 | 2,000 | $185,320.00 | 214,030 | 2026-10-21 | Filing | |
| $91.76 | 2,985 | $273,903.60 | 216,030 | 2026-10-21 | Filing | |
| $90.98 | 5,101 | $464,088.98 | 219,015 | 2026-10-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,229,245 | $211,332,426 | 0.01% | |
| 2. | 1,042,892 | $98,884,316 | 0.01% | |
| 3. | 916,300 | $86,865,240 | 0.01% | |
| 4. | 437,580 | $41,482,617 | 0% | |
| 5. | 262,986 | $24,918,284 | 0% |
News See All
Kodiak Sciences (KOD) Races Toward Three Make-Or-Break Trial Verdicts
On August 13, Kodiak Sciences Inc. (NASDAQ:KOD) reported second-quarter financial results for the period ended June 30, alongside an update on its three late-stage eye disease programs.
3 Best Stocks With 75%+ Upside to Buy This Week, According to Analysts
Analysts see strong momentum in some stocks this week, including Kodiak Sciences ($KOD), Archer Aviation ($ACHR), and CleanSpark ($CLSK). While eac...
10 Best 52-Week High US Stocks to Buy
In this article, we will discuss the 10 Best 52-Week High US Stocks to Buy.
8 Healthcare Stocks Insiders Are Buying
In this article, we will look at the 8 Healthcare Stocks Insiders Are Buying. Insider buying tends to draw attention because insiders know their companies best.
Kodiak Sciences (KOD) Climbs 75% on Stellar Clinical Results
Kodiak Sciences Inc. (NASDAQ:KOD) is one of the 10 Stocks Investors Dominating the Market Today.
10 Stocks Dominating The Market Today: Best Buy, Figma, Navan, and More
Ten stocks stood firmer on Thursday, bucking a bloodbath in the broader market, as investors took heart from corporate developments such as strong earnings and outlooks, among others.
Jim Cramer Shared Insights on These 18 Stocks
On Tuesday, Mad Money host Jim Cramer addressed concerns surrounding President Donald Trump’s attempt to remove a Federal Reserve Board governor, a move many consider legally questionable, and why he...
10 Hot Biotech Stocks Under $5
In this article, we will look at 10 Hot Biotech Stocks Under $5.
Why These 24 Stocks Are Skyrocketing
One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.